0000908662-16-000397.txt : 20160115 0000908662-16-000397.hdr.sgml : 20160115 20160115162310 ACCESSION NUMBER: 0000908662-16-000397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160114 FILED AS OF DATE: 20160115 DATE AS OF CHANGE: 20160115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYAX CORP CENTRAL INDEX KEY: 0000907562 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043053198 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 BUSINESS PHONE: 617-250-5769 MAIL ADDRESS: STREET 1: 55 NETWORK DRIVE CITY: BURLINGTON STATE: MA ZIP: 01803-2756 FORMER COMPANY: FORMER CONFORMED NAME: BIOTAGE INC DATE OF NAME CHANGE: 19951117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Gustav CENTRAL INDEX KEY: 0001397709 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24537 FILM NUMBER: 161345716 MAIL ADDRESS: STREET 1: DYAX CORP. STREET 2: 300 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-01-14 0000907562 DYAX CORP DYAX 0001397709 Christensen Gustav C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803-2756 1 1 0 0 CEO and President Common Stock 2016-01-14 4 M 0 523955 1.41 A 1047134 D Common Stock 2016-01-14 4 M 0 87500 1.48 A 1134634 D Common Stock 2016-01-14 4 M 0 333333 2.06 A 1467967 D Common Stock 2016-01-14 4 M 0 93749 2.06 A 1561716 D Common Stock 2016-01-14 4 M 0 93750 2.06 A 1655466 D Common Stock 2016-01-14 4 M 0 46874 2.06 A 1702340 D Common Stock 2016-01-14 4 M 0 57000 2.06 A 1759340 D Common Stock 2016-01-14 4 M 0 218749 2.06 A 1978089 D Common Stock 2016-01-14 4 M 0 207033 3.00 A 2185122 D Common Stock 2016-01-14 4 M 0 137500 10.20 A 2322622 D Common Stock 2016-01-14 4 M 0 125000 15.23 A 2447622 D Stock Option (right to buy) 1.91 2016-01-14 4 M 0 523955 0 D 2021-02-10 Common Stock 523955 0 D Stock Option (right to buy) 1.48 2016-01-14 4 M 0 87500 0 D 2022-02-24 Common Stock 87500 12500 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 333333 0 D 2020-02-10 Common Stock 333333 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 93749 0 D 2018-08-07 Common Stock 93749 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 93750 0 D 2018-02-13 Common Stock 93750 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 46874 0 D 2017-07-02 Common Stock 46874 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 57000 0 D 2017-06-20 Common Stock 57000 0 D Stock Option (right to buy) 2.06 2016-01-14 4 M 0 218749 0 D 2019-01-02 Common Stock 218749 0 D Stock Option (right to buy) 3.00 2016-01-14 4 M 0 207033 0 D 2023-02-07 Common Stock 207033 108333 D Stock Option (right to buy) 10.20 2016-01-14 4 M 0 137500 0 D 2024-02-27 Common Stock 137500 162500 D Stock Option (right to buy) 15.23 2016-01-14 4 M 0 125000 0 D 2025-02-18 Common Stock 125000 475000 D The options were fully exercisable as of February 10, 2015. The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 24, 2012. The options were fully exercisable as of June 20, 2014. The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 7, 2013. The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 27, 2014. The options become exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant, February 18, 2015. /s/ Stacie S. Aarestad as attorney-in-fact 2016-01-15